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Thrombolytic therapy has been shown to be effective in
reopening totally occluded arteries in acute myocardial
infarction. Coronary thrombus is also believed to play
a role in the pathophysiology of unstable angina and
non-Q wave infarction. However, few patients with these
two acute coronary syndromes have been treated with
intracoronary streptokinase. Therefore, 100,000 to
300,000 IV (mean 177,000 ± 80,000 IV) of Intracoro-
nary streptokinase was infused into 36 consecutive cath-
eterized patients who either presented with an acute ep-
isode of unstable angina or had had a recent non-Q wave
infarction and in whom a < 100% occluded ischemia-
producing artery could be identified. Qualitative tech-
niques utilizing vessel magnification and quantitative
analysis with digital subtraction were performed on the
ischemia-producing coronary lesion before and imme-
diately after streptokinase therapy and 3 to 10days later
in 18 patients who were restudied at the time of trans-
luminal coronary angioplasty.
Before streptokinase treatment, 24 (67%) of 36 is-
chemia-producing arteries contained eccentric, irregu-
lar lesions.The percent diameterstenosisand percent area
stenosis in all ischemia-producing arteries averaged 83.8
± 8.3% and 94.8 ± 3.3%, respectively. After strep-
In the past few years there has been increasing clinical .
angiographic and pathologic evidence to suggest a role for
coronary thrombus in the pathogenesis of unstable angina.
By defirtition , unstable angina presents as either an acute
increase in symptoms or the acute onset of Canadian Heart
Association class III or IV angina or rest pain . This in itself
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tokinase treatment there were 23 arteries (64%) with
eccentric irregular lesions. The percent diameter stenosis
and percent area stenosis in all ischemia-producing ar-
teries were similar to pre-streptokinase values (82.9 ±
5.9% and 93.8 ± 4.0%, respectively). At restudy , there
were also no significant changes in any quantitative or
qualitative variable. Five individual patients showed a
significant reduction in percent stenosis after strepto-
kinase. This improvement was independent of duration
of symptoms, use of heparin before angiography , strep-
tokinase dose or reduction of fibrinogen levelspost-strep-
tokinase. Two additional patients deteriorated clinically
and developed total occlusion of the ischemia-producing
artery within 12 hours of streptokinase infusion.
These data suggest that intracoronary streptokinase
may be of limited utility in either unstable angina or
recent non-Q wave infarction with a < 100% occluded
ischemia-producing artery. In these syndromes, throm-
bus may be organized or short infusions may be given
too late to be effective. In some cases, thrombus may
even be absent. Whether longer infusion of streptokinase
or other thrombolytic agents will be of benefit remains
to be determined.
(J Am Coil CardioI1987,"9:1156-65)
suggests an acute decrease in coronary perfusion relative to
oxygen demand . Angiographically, we have shown (I) in
approximately two-thirds of such patients with a < I00%
occluded ischemia-producing artery that a specific mor-
phology was present. An eccentric stenosis with overhang-
ing edges or irregular borders, or both , (type II eccentric)
was characteristically found , and this lesion was uncommon
in ischemia-producing arteries in stable angina pectoris . In
addition. this lesion was similar to that found in acute or
recent myocardial infarction with < 100% occluded arteries
(2). Pathologically. this lesion possibly represents a dis-
rupted plaque or thrombu s, or both . Previous pathologic
studies (3-5) of the coronary arteries have shown that, in
patients who die soon after an episode of unstable angina.
0735-1097/87/$3.50
lACC Vol. 9. No.5
May J987:1156-65
AMBROSE ET AL
THROMBOLYSIS IN UNSTABLE ANGINA AND NON-Q WAVE INFARCTION
1157
thrombus is usually present and it is anchored to a disruption
of the atheroscleroticplaque. In addition to our angiographic
findings in unstable angina, other angiographic studies (6,7)
have shown a high incidence of a filling defect consistent
with a thrombus within or distal to obstructive coronary
lesions in unstable angina and non-Q wave infarction. These
thrombi are especially common in those patients studied
soon after the onset of symptoms. Recently, preliminary
data (8) utilizing angioscopy have demonstrated that intra-
coronary thrombus is frequent in ischemia-producing arter-
ies in unstable angina.
Although these data suggest that intracoronary thrombus
is often present in patients with these acute coronary syn-
dromes, only a few studies have examined the role of throm-
bolytic therapy (9-11). In none of these studies was the
coronary morphology of the responsible lesion character-
ized, nor was quantitative coronary arteriography utilized
to determine its response to thrombolytic therapy. There-
fore, in this study we examined the qualitative and quan-
titative effects of intracoronary streptokinase in unstable
angina and non-Q wave infarction with < 100% stenosis of
ischemia-producing arteries. Specifically, to further ascer-
tain the role of thrombus in these syndromes, we evaluated
changes in the morphology or severity of stenosis in is-
chemia-producing arteries after intracoronary infusions of
streptokinase.
Methods
Patient selection. Since July 1985 we have prospec-
tively enrolled patients in a study to test the efficacy of
intracoronary streptokinase in unstable angina and non-Q
wave infarction. This study was approved by our hospital's
institutional review board. All patients admitted to the hos-
pital with a diagnosis of unstable angina or non-Q wave
infarction were eligible for study. The decision to perform
cardiac catheterization and the therapy that the patient re-
ceived before catheterization were determined indepen-
dently by the cardiologist caring for the patient. Unstable
angina was defined as follows: I) the new onset of class III
or IV symptoms utilizing the Canadian Heart Association
classification or the new onset of rest pain occurring within
6 months of cardiac catheterization; 2) crescendo angina,
defined as a significant increase in the frequency or severity
of previous stable angina. All patients with crescendo angina
had to have at least class IV symptoms or rest pain, or both.
No patient with a diagnosis of unstable angina had persistent
ST and T wave changes on the electrocardiogram (ECG)
after episodes of chest pain. No patient had elevations of
creatine kinase greater than twice normal. A diagnosis of
non-Q wave infarction was made by the presence of > 30
minutes of chest pain associated either with new and per-
sistent ST and T wave changes (>48 hours) on the ECG
without Q waves or elevation of creatine kinase greater than
twice normal.
Inclusion and exclusion criteria. All patients who
underwent cardiac catheterization with a diagnosis of un-
stable angina or non-Q infarction were eligible for intra-
coronary infusion of streptokinase. Patients with the fol-
lowing conditions were excluded before catheterization for
considerationof intracoronarythrombolytic therapy: I) con-
comitant valvular heart disease; 2) status post coronary ar-
tery bypass surgery or coronary angioplasty; 3) Q wave
infarction within I month of catheterization; 4) refusal to
participate in the study; and 5) a contraindication to the use
of thrombolytic therapy, such as significant anemia, recent
history of bleeding, recent surgery, recent cerebrovascular
accident or age>77 years.
After obtaining informed consent, diagnostic catheter-
ization was performed. Patients were excluded from intra-
coronary streptokinase therapy if at the time of diagnostic
angiography no significantcoronary artery disease was pres-
ent «70% narrowing in a large coronary artery branch),
an ischemia-producing artery with :::::70% to < 100%occlu-
sion could not be identified or if significant left main coro-
nary artery stenosis (::::: 70°,{:) was present. All patients with
an ischemia-producing artery that was totally occluded were
excluded because of the inability to characterize the coro-
nary morphology.
Criteria for identification of ischemia-producing ar-
teries. An ischemia-producing artery was defined at the
time of catheterization as an artery with a stenosis that
visually appeared>70% stenotic (diameter stenosis) in a
major coronary branch. An artery was selected as ischemia
producing in all patients with significantone vesselcoronary
artery disease. In patients with multivessel coronary artery
disease, an ischemia-producing artery was selected under
the following circumstances: I) there was a significant ob-
struction in a major branch that subserved myocardium with
either normal or hypokinetic wall motion. This vessel was
designated as the ischemia-producing artery if all other ar-
teries with significant obstruction subserved akinetic myo-
cardium and there had been a clinical history of myocardial
infarction or Q waves on ECG in the distribution of that
akinetic area. 2) Significant ECG changes during episodes
of rest pain localized an ischemia-producing artery in some
cases. That is, inferior ST and T wave changes localized a
dominant right coronary artery as the ischemia-producing
artery if this artery had a significant obstruction and there
was no significant disease in a large circumflex branch or
in a large left anterior descending artery wrapping around
the apex. Anterior ST and T wave changes during chest
pain localized the ischemia-producing artery to the left an-
terior descending artery if it had a significant obstruction
and if no significant disease was present in a large left
circumflexartery. If no ischemia-producingartery was iden-
tifiedat the time of catheterization, the patient was excluded
from the streptokinase protocol. These criteria for identi-
fication of ischemia-producing arteries were similar to those
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previouslyreported (I). If more than one lesion was present
in a presumed ischemia-producing artery, an ischemia-pro-
ducing lesion was selected only if quantitative measure-
ments showed a difference of at least 20% between the two
lesions. The more severe lesion was arbitrarily selected as
ischemia producing (this occurred in four patients).
Streptokinase protocol. Ifan ischemia-producing artery
was identified at the time of catheterization, the following
protocol was undertaken:
I) Digital angiography was performed of the ischemia-
producing artery in a single projection. The projection se-
lectedminimizedforeshortening andoverlapof othervessels
with the lesion in question.
2) Intracoronary streptokinase was then infused for 30 to
40 minutes into the ostium of the left or right coronary
artery, dependingon the locationof the ischemia-producing
lesion. In the first 21 patients, 100,000 to 199,000 IV of
intracoronary streptokinase was infused; in the last 15 pa-
tients, 200,000 to 300,000 ]V was infused over the 40
minute period. In patients receiving the higher dosage of
streptokinase, a loading dose of 60,000 IV was adminis-
tered, followed by an infusion of 4,000 to 8,000 Il.l/rnin.
All patients received between 7,000 and 10,000 units of
intravenous heparin before the infusion of streptokinase.
3) After the infusion of streptokinase, another digital
coronary angiogram was performed in exactly the same
projection and compared with the pre-streptokinase digital
study for both quantitative and qualitative aspects of the
coronary lesion.
4) Any nitroglycerin given before the infusion at the time
of the first digital study was also repeatedafter streptokinase
treatment at the time of the seconddigital study to minimize
the effects of coronary vasodilator on the quantification of
coronary stenoses.
5) After the infusionof streptokinase, patients were usu-
ally returned to the intensive care unit, where a continuous
infusionof intravenous heparin was routinely administered.
Patients referred for coronary angioplasty had a repeat dig-
ital angiogram of the ischemia-producing artery before an-
gioplasty in the same projection as the prior study. Quan-
titative and qualitative measurements of that stenosis were
then compared with the pre- and post-streptokinase digital
studies.
All patients undergoing this protocol were followed up
after catheterization until the patient was discharged or until
another procedure was performed (angioplasty or coronary
bypass surgery).
Study patients. Thirty-seven consecutive patients who
met the preceding criteria were enrolled in the study and
received intracoronary streptokinase. Fifty-three other pa-
tients were accepted for study and not given streptokinase.
In most instances this was due to an inability to define an
ischemia-producing vessel in patients with multivessel dis-
ease (18 patients), normal or nonobstructive coronary ar-
teries on angiography (15 patients) or significant left main
coronary artery disease (7 patients). Only 4 of the 53 ex-
cluded patients had a totally occluded ischemia-producing
artery. Of the 37 patients given streptokinase, 29 had un-
stable angina and 8 had non-Q wave infarction. Eighteen
patients were restudied 3 to 10 days later at the time of
angioplasty. One patient with rest pain and unstable angina
developed a severe allergic reaction to streptokinase before
completion of the infusion. A post-streptokinase digital study
was not performed in this patient and he was excluded from
the subsequent analysis, leaving 36 patients as the study
group.
Clinical data. There were 27 men and 9 women whose
ages ranged between 37 and 73 years (mean 60). Of the 36
patients studied, 18 had been in an intensivecare unit before
their first angiogram. Twenty-seven had been treated with
nitratesand 21 witha beta-adrenergic blockingagent. Nine-
teen were treated with a calcium channel blocker and 12
were receiving intravenous nitroglycerin before catheteriza-
tion. In addition, 20 patients were treated with intravenous
heparin before their first angiogram. The median length of
time from the onset of clinical instability to the first angio-
gram was 2.5 weeks(range0.5 to 12). In all patientsstudied
after 2 weeks of instability, catheterization was performed
because of progressive symptoms; 10 patients were studied
within I week of onset of instability. Twenty-four patients
had their typical anginal chest pain within 48 hours of cath-
eterization and J7 had angina within 24 hours of catheter-
ization. The mean dose of streptokinase was 177,000 ±
80,000 IV.
Angiographic data. Fifteen of the 36 patients given
streptokinase had one vessel disease whereas 21 had mul-
tivessel coronaryarterydisease. In 19patients, the ischemia-
producing artery was the left anterior descending coronary
artery, whereas in 6 it was the left circumflex and in II the
right coronary artery.
Quantitative Coronary Techniques
Image processing. Quantitativeanalysisof coronaryste-
noses was performed using images acquired with a Fischer
Imaging OF-100 digital subtraction angiographic unit cou-
pled to a Philips Cardiodiagnost 100 X-ray generator. Dig-
ital exposures were obtained for up to 10 seconds at 30
frames/s with a 512 X 512 pixel matrix, after an initial test
modewas performedto optimize imagequality. Pulse width
was 5 ms for all exposures, voltage ranged from 50 to 75
kY and average current was 250 mAo Images were stored
on a harddisc for laterprocessing. A projection was selected
that minimized the amountof foreshortening of the coronary
stenosis of interest. Every attempt was made to image the
stenosis in the middle portion of the image intensifier field
to minimize pincushion distortion. Also, coronary segments
of interestwere imaged, whenpossible, away from the lung
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Figure I. Quantitative methods for quantifying percent diameter
stenosis in a single plane. A, Digital caliper method. B, Video-
densitometric method. In both images. the " normal" segment in
thisparticularcasewas chosen distal to thelevelofstenosis. Arrow
points to the segment of the rightcoronary artery where the mea-
surements were taken.
fi elds to avoid blooming and veiling glare. Once an optimal
projection was selected. the same projection angle was used
for subsequent exposures.
Processing of digital images consisted of mask mode
subtraction of a noncontrast-containing end-diastolic image
from a contrast-containing end-diastolic image. Images were
magnified two- to fourfold on a video screen for quantitative
analysis. Coronary stenoses were quantifi ed by two inde-
pendent techniques of measurement (Fig. I). The first tech-
nique involved the use of digital caliper measurements ap-
plied to the digital acquisitions obtained from the study
patient before and after streptokinase treatment. and at the
time of restudy before angioplasty in those patients who
underwent angioplasty during their hospital stay. The per-
cent diameter stenosis was determined by comparison of a
user-defined diseased segment to a user-defined local seg-
ment that was considered normal. Minimal diameter was
derived from the diseased segment by calibration with a I
Col grid digitally acquired at the same angle and height from
the image intensifier as the patient' s study. The second
method used to quantify coronary stenoses was a video-
densitometric analysis of the logarithmically converted. mask
mode subtracted images. In this method. the operator defines
a region of interest over the diseased coronary segment and
a region of interest over a normal local segment. Areas on
either side of the normal and abnormal segment are also
selected for use in background correction. The program
compares the integrated videodensity of the normal with
those of the abnormal segments after background correction
and expresses the result as percent area stenosis.
Validation studies. Contrast-filled phantoms were con-
structed by means of precision drilled holes ranging in size
from 0.4 to 4.4 mm, made into a plastic block and fashioned
to give the appearance of stenotic segments varying in se-
verity from 63.3 to 92.2% diameter stenosis. The contrast-
fill ed phantom was digitally imaged over a patient to provide
a variable background. Both quantitative techniques de-
scribed were applied to mask subtracted phantom images.
For percent diameter stenosis by digital caliper measurement
r = 0.954 and SEE = 2.9%; for percent area stenosis by
videodensity r = 0.937 and SEE = 1.9%.
lnterobserver variability was tested using a group of dig-
ital images from patients undergoing routine digital angio-
grams. The same image was processed by two observers
with experience in performing the quantitative techniques.
For percent diameter stenosis r = 0.862 and SEE = 6.7%
and for percent area stenosis r = 0.947 and SEE = 2.4%.
Reproducibility was also tested using serial digital ac-
quisitions performed in similar projections on the same pa-
tient separated in time by several minutes. Figure 2 shows
the linear regression lines and 95% confidence bands for
percent diameter stenosis and percent area stenosis.
Digital images on patients were obtained using the same
projection angle for all subsequent images acquired for that
patient. In addition, the distance from tube to object and
from object to image intensifier was also kept constant. The
quantitative methods were applied using the same locations
for the normal coronary segments for repeat studies. The
width of the videodensitometric area of interest and back-
ground areas was also kept constant for serial studies. The
confidence bands in Figure 2 were used to define a signif-
icant change in coronary stenosis that might have resulted
from the streptokinase treatment. A significant improvement
or worsening of a coronary stenosis after streptokinase in-
fusion was characterized by an approximate 5% change with
digital calipers or a 7% change with videodensitometry.
The videodensitometric technique systematically under-
estimated stenosis severity with phantom and patient studies
when compared with values obtained using digital calipers.
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Figure2. Reproducibility of methods for
quantifying percent diameter stenosis. A,
Digital caliper method. B, Videodensi-
tometric method. For each point on the
curve, a lesion was visualized twice in
the same projection separated in time by
several minutes. The dotted lines repre-
sent the confidence bands.
There are multiple reasons for this, including lack of scatter
correction, mask misregistration artifacts. inadequate back-
ground correction, and so on. Because we were primarily
interested in precision (reproducibility) in our measure-
ments, we utilized this technique in conjunction with the
digital caliper method. Despite this systematic error with
videodensitometry. we found that this technique correlated
better than did digital calipers in patient studies involving
coronary lesions viewed orthogonally. In 14 lesions viewed
in orthogonal projections, the correlation with videodensi-
tometry was r = 0.962 and SEE = 2.0%; whereas for
digital calipers it was r = 0.785 and SEE = 6.5%. The-
oretically, this better correlation was expected with video-
densitometry because it was independent of lesion geome-
try.
Qualitative Coronary Techniques
Analysis of coronary morphology was performed as pre-
viously described (I). Reproducibility has also been pre-
viously reported. Coronary lesions were qualitatively char-
acterized by two or more angiographers using orthogonal
views. All assessments of morphology were done from cine
film that was magnified four- to fivefold on the angiographic
projector. Coronary lesions were placed in one of four groups
(Fig. 3):
I) Concentric lesion: symmetric, hourglass narrowing of
the coronary artery. which usually had smooth borders.
2 and 3) Eccentric lesion: an asymmetric narrowing. Two
types were identified. A type I eccentric lesion was an
asymmetric narrowing of the artery with smooth borders.
This category also included a lesion that was a convex
intraluminal obstruction with wide neck and smooth bor-
ders. A type II eccentric narrowing was an asymmetric
obstruction in the form of a convex intraluminal obstruction.
The neck of this lesion was narrowed because of one or
more overhanging edges and the borders were irregular or
scalloped. This lesion was that previously described in the
majority of ischemia-producing arteries in unstable angina
and acute or recent myocardial infarction.
4) Multiple irregularities: three or more serial obstruc-
tions within a coronary artery or an artery with severe diffuse
disease.
Subsequent to a recent report on the coronary morphol-
ogy of myocardial infarction by Wilson et al. (12) in which
an "ulcerated" lesion of the coronary artery was described
Figure 3. Schematic drawings of the different configurations of
coronary stenotic lesions. Concentric lesions were symmetric and
usually smooth. Type I eccentric lesions were asymmetric and
smooth and most were of the type depicted at the right of the
drawing. Type II eccentric lesions were either smooth with a nar-
row neck due to overhanging edges (left side) or had irregular
borders (right side). Multiple irregularities included vessels with
serial lesions or severe diffuse disease. (Reprinted with permission
from Ambrose et al. [II.)
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Table l. Quantitative Data in All 36 Patients
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Caliper" (%)
Videodensitometryt (Ok,)
Significant changes in
either
Minimal diameter (mm)
Before SK
838 ± 8.3
l,J4.8 ± 3.3
0.44 ± 0.27
p Value
NS
NS
NS
After SK
82.l,J ± 5.l,J
l,J3.8 ± 4.0
5 Improved/I worsened
0.44 ± 0.21
Results are mean ± I SD; *percent diameter stenosis; tpercent area stenosis; SK = streptokinase.
in ischemia-producing vessels, we specifically noted the
appearance of this particular lesion in our study group. In
addition to this qualitative assessment of coronary mor-
phology, the presence of filling defects distal to a significant
coronary lesion was noted. These were defined as intralu-
minal radiolucencies distal to a coronary stenosis that were
surrounded by contrast on at least three sides.
Fibrinogen determination. The heat precipitation method
was used to assay fibrinogen levels (13) immediately before
and immediately after the infusion of streptokinase. This
method was utilized because the assay is not interfered with
by the presence of heparin or fibrin degradation products.
Statistics. Comparisons were made using a chi-square
or two-tailed Student's t test with the Bonferroni correction
used for multiple comparisons. All results were expressed
as mean ± I SD. Linear regression equations were cal-
culated using the least squares method. Confidence bands
for these equations were calculated using prediction inter-
vals (14).
Results
Quantitative data. Table I includes the quantitative
coronary analyses in patients before and after streptokinase
treatment. Because the number of patients with non-Q wave
infarction was small and because we have seen similar
coronary morphology and percent stenosis for ischemia-
producing arteries in patients with unstable angina and non-
Q wave infarction (15), we did not separate the two groups
but analyzed their data together. Pre-streptokinase caliper
and videodensitometric measurements for the entire group
were 83.8 ± 8.3% diameter stenosis and 94.8 ± 3.3%
area stenosis, respectively. After the infusion of streptoki-
nase, there was no significant change in the mean value for
either measurement. A typical lesion visualized both before
and after streptokinase is shown in Figure 4. Five patients
showed a significant reduction in percent stenosis after strep-
tokinase, whereas in one patient the artery became totally
occluded (see later). When these quantitative data were ana-
lyzed in relation to streptokinase dose «200,000 versus
~200,000 IV), there were no significant differences in the
pre-streptokinase percent stenosis or in the response to strep-
tokinase.
Qualitative data. The coronary morphologic findings in
all 36 patients are listed in Table 2. Twenty-four (67%) of
36 arteries contained a type II eccentric lesion. After strep-
tokinase treatment only one artery changed morphology; this
lesion went from a type II eccentric to total occlusion. Only
one lesion had the angiographic appearance of the ulcerated
lesion reported by Wilson et al. (12). Distal filling defects
were noted in four patients before streptokinase and only
one defect lysed immediately after the infusion.
Figure 4. Pre-and post-streptokinase imagesof a type II eccentric
lesion in the left anterior descending artery in the right anterior
oblique projection. There was no change in the percent diameter
or percent area stenosis after streptokinase.
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Restudy data. Eighteen patients with suitable anatomy
underwent coronary angioplasty. The quantitative and qual-
itative coronary data of these patients at restudy are sum-
marized in Table 3. There were no differences in the quan-
titative analysis performed before angioplasty when compared
with the pre- and post-streptokinase values. Two arteries
showed a significant reduction in the percent stenosis at
restudy, whereas four showed a significant increase.
At restudy, 9 of 18 lesions were type 11 eccentric. This
represented a change in morphology from the post-strep-
tokinase study of only one lesion, which progressed from
type II eccentric to total occlusion, In one artery with a
filling defect after streptokinase, the defect disappeared at
restudy. Two other patients with a filling defect after strep-
tokinase were not restudied.
Improvement after streptokinase. Five patients had a
significant reduction in the percent coronary stenosis after
streptokinase as assessed utilizing the confidence limits de-
fined in our validation studies, This improvement was noted
by the caliper method in all five and by videodensitometry
in one; in four of the five, the improvement was < 10%.
Patients with and without stenosis reduction did not differ
significantly in age, duration of unstable symptoms, use of
heparin before angiography, streptokinase dose or change
in fibrinogen after streptokinase treatment. A trend was noted
between the last episode of chest pain before streptokinase
and reduction in the percent stenosis after streptokinase: 18
± 24 and 59 ± 50 hours, respectively, in patients with
and without stenosis reduction (p < 0.1). Four of 17 patients
studied within 24 hours of an episode of angina demon-
*"Ulcerated lesion" (12); SK = streptokinase.
Table 2. Qualitative Data in All 36 Patients
Morphology
Concentric
Type I eccentric
Type II eccentric
Multiple irregularities
Other morphology*
Total occlusions
Filling defects
Before SK
7
4
24
o
I
o
4
After SK
7
4
23
o
I
I
3
strated improvement by digital techniques after streptoki-
nase treatment.
Heparin therapy before streptokinase. Quantitative
assessment of patients who were not pretreated with heparin
before angiography (Table 4) showed that they had a more
severe area stenosis in the angina-producing vessel (p <
0.01) than those patients pretreated with heparin. Percent
diameter stenosis was also more severe and minimal di-
ameter was less in those not receiving heparin, but the
differences were not significant. Coronary morphology was
similar. Two patients with a distal filling defect had been
pretreated with heparin, whereas two others had not. the
response to streptokinase was also similar between groups.
In addition to these small but significant differences in
area stenosis, there were other significant differences be-
tween patients who did and did not receive heparin. Patients
pretreated with heparin were more likely to be located in
an intensive care unit before angiography (14 of 20 versus
4 of 16, P < 0.0 I) and were more likely to be receiving
intravenous nitrogycerin (II of 20 versus I of 16, p < 0.0 I)
respectively. Pre- and post-streptokinase values did not dif-
fer between patients who were studied within I week of
onset of symptoms and those studied after a longer duration
of symptoms.
Fibrinogen determination. Before streptokinase, fi-
brinogen levels were 297 ± 79 mg/liter, whereas after strep-
tokinase they dropped to 230 ± 76 mg/liter (p < 0.05),
Fibrinogen decreased by > 10% in 67% of patients and by
< 10% in 33%. There were no significant differences in any
quantitative or qualitative variable either before or after
streptokinase between patients who had a decrease in fi-
brinogen versus those who did not. In addition, the dose of
streptokinase was similar in the two groups,
Clinical follow-up. In most patients there was no ob-
vious change in the frequency or severity of symptoms after
streptokinase; However, two patients developed severe chest
pain with ST segment elevation in the distribution of the
ischemia-producing artery within 12 hours of the infusion.
One of these patients was immediately restudied and the
artery was noted to be occluded. The second patient sus-
tained an uncomplicated anterior wall myocardial infarction.
Two other patients noted a definite worsening of chest pain
after streptokinase.
Table 3. Quantitative and Qualitative Data in 18 Patients at Restudy
Caliper (%)
Videodensitometry (%)
Significant change in either
Type II eccentric
Non-type II eccentric*
Before SK
84.0 ± 4.6
94,9 ± 2.5
10/18
8/18
After SK
82.0 ± 5.3
93.9 ± 4.6
I Improved
10118
8/18
Restudy
81.4 ± 9.7
93.4 ± 5.8
2 Improved/4 worsened
9/18
9/18
p = NS for all groups; *all other morphologies excluding type II eccentric.
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Table 4. Effects of Pretreatment with Heparin on Streptokinase Analysis and the Response to Streptokinase
Before SK After SK*
Heparin No Heparin Heparin No Heparin
(n = 20) P Value (n = 16) (n = 20) P Value (n = 16)
Videodensity (%) 93.4 ± 3.4 < 0.01 96.3 ± 2.3 927 ± 2.0 NS 95.1 ± 4.8
Caliper (%) 81.5 ± 9.9 NS 86.7 ± 4.4 81.4 ± 6.0 NS 84.6 ± 5.5
Minimal 0.49 ± 0.30 NS 0.36 ± 0.20 O.4H ± 0.22 NS 0.41 ± 0.21
diameter (mrn)
Type II eccentric 15/20 NS 9116 15/20 NS 8/16
Non-type II 5/20 NS 7116 5/20 NS 8/16
eccentric
*After SK, there were no statistical differences to any value before SK; SK = streptokinase.
Discussion
Intracoronary thrombolytic therapy is effective in re-
opening 100% occluded coronary arteries in acute myo-
cardial infarction. Intracoronary infusion of streptokinase is
effective in approximately 70 to 80% of cases (16,17). In
patients with < 100% occluded infarct vessel, the results are
more variable. In the small number of patients described
(9,18), there is usually little change in the percent stenosis
after streptokinase.
Previous studies. Few patients with unstable angina have
been treated with thrombolytic therapy. Lawrence et al. (19)
conducted a prospective randomized study of intravenous
thrombolytic therapy in 40 patients with unstable angina.
Of these patients, who had recent onset or progressive an-
gina, 20 were given 24 hours of intravenous streptokinase
followed by warfarin and 20 received warfarin alone. At
the end of 6 months, only I of the 20 patients treated with
streptokinase experienced a significant cardiac event, com-
pared with 8 of the 20 patients treated with warfarin alone.
Although these two groups were clinically similar, no coro-
nary arteriography was performed. Other smaller studies
have reported the variable effects of intracoronary strepto-
kinase in patients with unstable angina and non-Q wave
infarction. Rentrop et al. (9) studied five patients with un-
stable angina and found no angiographic change in the ap-
pearance of subtotal lesions after infusion of streptokinase.
On the other hand, Vetrovec et al. (10) found clinical im-
provement in 10 of 13 patients with unstable angina treated
with intracoronary streptokinase, although in the majority
only minor angiographic improvement in percent diameter
was present. Mandelkorn et al. ( II ) found a > 10% reduction
in percent stenosis in 7 of 17 patients with unstable angina
or non-Q infarction after intracoronary streptokinase.
Present study. Our study reports for the first time the
quantitative and qualitative effects of intracoronary strep-
tokinase in a consecutive group of catheterized patients with
either unstable angina or non-Q wave infarction. Strepto-
kinase was usually ineffective in reducing the percent ste-
nosis in the angina-producing vessel. In the few patients in
whom a significant change in coronary diameter occurred
after thrombolytic therapy, the decrease in percent stenosis
was usually < 10%. The change in percent stenosis after
streptokinase infusion appeared unrelated to the dose or to
the change in fibrinogen levels after infusion. Although
patients receiving heparin infusion before angiography had
a less severe lesion in the angina-producing vessel than those
not pretreated with heparin, the response to streptokinase
was similar in that significant changes in percent stenosis
or in minimal stenosis diameter were not seen. The differ-
ences in percent stenosis before streptokinase may have been
related to a protective effect of heparin in dissolving small
amounts of intracoronary thrombus. However, we could not
exclude other confounding variables, that is, patients treated
with heparin were more likely to be receiving intravenous
nitroglycerin than were those not pretreated with heparin.
Patients experiencing a significant improvement in the per-
cent stenosis after streptokinase treatment tended to have
had more recent episodes of chest pain relative to catheter-
ization than did patients without improvement. This is par-
tially consistent with the data of Mandelkorn et al. (II) who
found that improvement after treatment with streptokinase
was limited to patients whose duration of rest pain was < I
week from the time of catheterization. However, we could
find no relation between the duration of clinical instability
before catheterization and the response to streptokinase. In
fact, in two-thirds of our patients angina had occurred within
48 hours of catheterization and in one-half within 24 hours.
Pathogenesis of acute coronary syndromes and the
role of streptokinase. Recent data suggest a primary role
for plaque disruption and thrombus in the pathogenesis of
the acute coronary syndromes. Why, then, should intra-
coronary streptokinase be ineffective therapy in most of
these patients? The pathologic data of Falk (4) showed lay-
ered thrombus in the coronary vessels of patients who died
after an episode of unstable angina. Thus, it is possible in
some patients with unstable angina that the thrombus de-
posited at the site of plaque disruption is already organized
within the coronary artery at the time of clinical presentation
and therefore is resistant to short infusions of streptokinase.
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Although progression of coronary disease is usually found
in patients with a history of stable angina catheterized after
an episode of unstable angina (20,21), the acute change in
symptoms often manifested by these patients may result
from more long-term changes within the coronary artery.
When plaque disruption occurs as a cause of unstable angina
and non-Q wave infarction, it is possible that the layering
of thrombus occurred slowly over days to weeks. Myo-
cardial ischemia manifesting as an acute episode of rest
angina occurs only when the amount of thrombus reaches
a critical size or when the lumen of the artery has been
transiently reduced to a critical minimal area. Platelet em-
bolization distal to the lesion might also explain unstable
symptoms in some of these patients.
Other factors in this study may have been responsible
for the lack of efficacy of streptokinase in unstable angina
and non-Q wave infarction: I) The delivery of streptokinase
may have been inadequate to lyse the thrombus responsible
for the patient's symptoms. The dosage, concentration or
length of infusion of streptokinase may not have been op-
timal. We could find no effect when the dose of strepto-
kinase was raised from 100,000 to 300,000 IV. In a non-
occluded artery with preserved anterograde flow, the
concentration of the drug at the thrombus site may not be
high enough to achieve thrombolysis. We did not evaluate
the effect of prolonged infusions of streptokinase. 2) Strep-
tokinase may have been given too late to be effective; that
is, thrombus was organized (as previously mentioned), re-
sistant to short infusions of streptokinase or even absent.
When we evaluated patients given streptokinase within I
week of onset of symptoms, as was shown to be effective
in one study of unstable angina (II), we could find no
benefit. To achieve thrombolysis, it may be necessary to
give the thrombolytic therapy within hours of onset of un-
stable symptoms. On the other hand, in patients with acute
myocardial infarction and < 100% occluded infarct vessel,
who are given streptokinase within 12 hours of onset of
symptoms, there is usually little change in the percent ste-
nosis. At the time of angiography, there may have been no
thrombus present in the plaque, except perhaps in the five
patients who showed an improvement after streptokinase
treatment. More than 50% of the patients had been treated
with heparin, which may have facilitated spontaneous
thrombolysis. In addition, the condition of some patients
had already stabilized before angiography. However, throm-
bus has been identified in the majority of patients with
unstable angina examined at postmortem or during angios-
copy.
Clinical implications. These data suggest that intracor-
onary streptokinase may be of limited use in unstable angina
and non-Q wave infarction with a < 100% occluded is-
chemia-producing artery. These findings support the hy-
pothesis that when thrombus is present in the coronary ar-
teries of patients with unstable symptoms, presumably at
the site of a disrupted atherosclerotic plaque, it is already
organized or resistant to short infusions of streptokinase, or
both. Whether longer infusions of streptokinase or other
thrombolytic agents will be of benefit in these conditions
remains to be determined. It must be emphasized that our
goal was to examine the morphometric effects of strepto-
kinase in these syndromes to better understand their path-
ophysiology. A placebo-controlled trial of thrombolytic
agents, preferably given immediately after the onset of un-
stable symptoms, might better determine whether throm-
bolytic therapy will be of clinical benefit.
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